Cadence Capital Management’s Dynavax Technologies DVAX Stock Holding History

Cadence Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-19,995	Closed	-$483K	–	638
2015 Q4	$483K	Buy	+19,995	New	+$501K	0.03%	475
2014 Q3	–	Sell	-66,314	Closed	-$1.06M	–	553
2014 Q2	$1.06M	Sell	66,314 -7,285	-10%	-$110K	0.05%	415
2014 Q1	$1.33M	Buy	+73,599	New	+$1.36M	0.06%	385

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Cadence Capital Management's DVAX Position: Q1 2016 in Review

Cadence Capital Management sold out of Dynavax Technologies (DVAX) in Q1 2016, closing a stake of 19,995 shares — an estimated $483K sold.

Cadence Capital Management first reported a position in DVAX in Q1 2014 and held it in 3 quarters. The position peaked at $1.33M in Q1 2014. 130 funds tracked by Wall St. Rank hold DVAX as of Q1 2016.

Cadence Capital Management reported no remaining Dynavax Technologies position as of Q1 2016 after selling out during the quarter.
Cadence Capital Management sold 19,995 Dynavax Technologies shares in Q1 2016, an estimated $483K.
Cadence Capital Management first reported a position in Dynavax Technologies in Q1 2014 and held it in 3 quarters.
Cadence Capital Management's Dynavax Technologies position peaked at $1.33M in Q1 2014.
130 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2016.

Based on Cadence Capital Management's 13F filing for Q1 2016, filed 2 May 2016.